Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | INCY | Common Stock | Options Exercise | $60K | +802 | +1.17% | $74.78 | 69.3K | Jan 31, 2023 | Direct | |
transaction | INCY | Common Stock | Sale | -$67.4K | -802 | -1.16% | $84.06 | 68.5K | Jan 31, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -802 | -100% | $0.00* | 0 | Jan 31, 2023 | Common Stock | 802 | $74.78 | Direct | F3 |
Id | Content |
---|---|
F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
F2 | Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
F3 | Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. |